Halozyme Therapeutics, Inc.
Could not find a ticker for this position, may be a filing error
A San Diego biopharma company whose ENHANZE technology uses a naturally occurring enzyme to temporarily loosen the gel-like tissue under the skin, letting large-volume biologic medicines be injected in minutes instead of slowly dripped over hours. Its partners sell drugs built on this platform, such as DARZALEX FASPRO and HYQVIA, and it also makes auto-injector devices and its own products like XYOSTED. Co-founded in 1998 by Dr. Gregory Frost, the company's name blends "hyaluronidase" and "enzyme" — the very molecule its science revolves around.
Senior unsecured convertible notes due March 1, 2027
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
5.07 Submission of Matters to a Vote of Security Holders
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 9.01 Financial Statements and Exhibits
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · 9.01 Financial Statements and Exhibits
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 9.01 Financial Statements and Exhibits